Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
270 participants
INTERVENTIONAL
2024-04-03
2026-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Texture and Colour Enhancement Imaging (TXI) Versus Dye Chromoendoscopy for Dysplasia Detection in IBD Surveillance.
NCT07208214
Back-to-back Endoscopy Versus Single-pass Endoscopy and Chromoendoscopy in IBD Surveillance
NCT04291976
Linked Color Imaging vs. White Light for Colorectal Dysplasia in Ulcerative Colitis
NCT02772406
Chromoscopic Guided Endomicroscpy to Diagnose Colitis Associated Dysplasia
NCT00352404
Linked-Color Imaging Versus Indigo Carmine Pump Spraying on the Colorectal Adenoma Detection Rate
NCT06961149
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dye Spray Chromoendoscopy
Patients undergoing surveillance with dye spray chromoendoscopy
Image Enhanced Endoscopy Filters
Patients that undergoing surveillance and consent to be involved in the study will be randomised to undergo surveillance with LCI, TXI or dye-spray chromoendoscopy (methylene blue).
TXI
Patients undergoing surveillance with TXI (Texture and Colour Enhancement Imaging)
Image Enhanced Endoscopy Filters
Patients that undergoing surveillance and consent to be involved in the study will be randomised to undergo surveillance with LCI, TXI or dye-spray chromoendoscopy (methylene blue).
LCI
Patients undergoing surveillance with LCI (Linked Colour Imaging )
Image Enhanced Endoscopy Filters
Patients that undergoing surveillance and consent to be involved in the study will be randomised to undergo surveillance with LCI, TXI or dye-spray chromoendoscopy (methylene blue).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Image Enhanced Endoscopy Filters
Patients that undergoing surveillance and consent to be involved in the study will be randomised to undergo surveillance with LCI, TXI or dye-spray chromoendoscopy (methylene blue).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Inadequate bowel preparation
* Previous surgical resection involving the colon
* History of bowel cancer
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Royal Perth Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sherman Picardo
Doctor, Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Royal Perth Hosptial
Perth, Western Australia, Australia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Sherman Picardo, MBBS
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Protocol V1.4_04012024
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.